Autolus Therapeutics plc Profit Margin

The latest profit margin for AUTL is -238.62% as of June 2026. That compares with -760.93% in the prior-year period — up 68.6% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Autolus Therapeutics plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, AUTL's profit margin moved from -760.93% to -238.62% — a 68.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Autolus Therapeutics plc's valuation or profitability profile.

Against Healthcare companies, AUTL currently prints -238.62% for profit margin, while the sector average sits near 13.89%. That is roughly 1817.5% below the sector mean. Large gaps often invite a closer look at Autolus Therapeutics plc's growth, margins, and balance sheet.

Profit Margin shows how effectively Autolus Therapeutics plc converts resources into returns. At -238.62%, AUTL may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -760.93% in the prior-year period — up 68.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting AUTL's profit margin (-238.62%), review year-over-year change from -760.93%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.